Pneumonia-induced sepsis and gut injury: Effects of a poly-(ADP-ribose) polymerase inhibitor

Journal of Surgical Research

Volumn 129, Issue 2, 2005, Pages 292-297

  Lobo, Suzana M ^a   Orrico, Susana R Perez ^a   Queiroz, Márcio M ^a   Cunrath, Geni S ^a   Chibeni, Gisela S A ^a   Contrin, Ligia M ^a   Cury, Patricia M ^a   De Almeida Burdmann, Emanuel ^a   De Oliveira Machado, Antonia M ^a   Togni, Paulo ^b   De Backer, Daniel ^c   Preiser, Jean Charles ^c   Szabó, Czaba ^d   Vincent, Jean Louis ^c  

^a HOSPITAL DE BASE   (Brazil)

^b FAMECA   (Brazil)

^c ERASME HOSPITAL   (Belgium)

^d INOTEK CORPORATION   (United States)

Author keywords

Bacterial translocation; Gut inflammation; Pseudomonas aeruginosa

Indexed keywords

BUFFER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BLOOD CULTURE; BLOOD FLOW; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENTERITIS; HISTOLOGY; HUMAN; INTESTINE; INTESTINE INJURY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; SEPSIS; SUPERIOR MESENTERIC ARTERY;

ANIMALS; AORTA; BLOOD PRESSURE; ENTERITIS; ENZYME INHIBITORS; INTESTINES; MESENTERIC ARTERY, SUPERIOR; PHENANTHRENES; PNEUMONIA, BACTERIAL; POLY(ADP-RIBOSE) POLYMERASES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS; REGIONAL BLOOD FLOW; SEPSIS; SPECIFIC PATHOGEN-FREE ORGANISMS; TRACHEA;

EID: 29144480267     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.05.018     Document Type: Article

References (36)

1. C.A. Greenaway, J. Embil, P.H. Orr, J. McLeod, B. Dyck, L.E. Nicolle Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital Infect. Control Hosp. Epidemiol 18 1997 749
2. A.A. Tejada, D.S. Bello, V.E. Chacon Risk factors for nosocomial pneumonia in critically ill trauma patients Crit. Care Med 29 2001 304
3. J. Valles, E. Mesalles, D. Mariscal A 7-year study of severe hospital-acquired pneumonia requiring ICU admission Intensive Care Med 29 2003 1981
4. O. Leroy, A. Meybeck, T. d'Escrivan Hospital-acquired pneumonia in critically ill patients Mortality risk stratification upon onset Treat. Respir. Med 3 2004 123
5. N. Sopena, M. Sabria Multicenter study of hospital-acquired pneumonia in non-ICU patients Chest 127 2005 213
6. S. Fiel Guidelines and critical pathways for severe hospital-acquired pneumonia Chest 119 2001 412S
7. H.T. Hassoun, B.C. Kone, D.W. Mercer, F.G. Moody, N.W. Weisbrodt, F.A. Moore Post-injury multiple organ failure The role of the gut Shock 15 2001 1
8. P. Yu, C.M. Martin Increased gut permeability and bacterial translocation in Pseudomonas pneumonia-induced sepsis Crit. Care Med 28 2000 2573
9. L. Liaudet, C. Szabo, O.V. Evgenov Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis Shock 19 2003 131
10. M.P. Fink Bench-to-bedside review Cytopathic hypoxia Crit. Care 6 2002 491
11. C. Szabo Role of poly(ADP-ribose) synthetase activation in the suppression of cellular energetics in response to nitric oxide and peroxynitrite Biochem. Soc. Trans 25 1997 919
12. D. Lautier, J. Lagueux, J. Thibodeau, L. Menard, G.G. Poirier Molecular and biochemical features of poly (ADP-ribose) metabolism Mol. Cell Biochem 122 1993 171
13. P. Jagtap, F.G. Soriano, L. Virag Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate- ribose) synthetase Potent cytoprotective and antishock agents Crit. Care Med 30 2002 1071
14. G.M. Wray, C.J. Hinds, C. Thiemermann Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin Shock 10 1998 13
15. P. Pacher, L. Liaudet, F.G. Soriano, J.G. Mabley, E. Szabo, C. Szabo The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes Diabetes 51 2002 514
16. Z. Ivanyi, B. Hauser, A. Pittner Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia Shock 19 2003 415
17. R.D. Goldfarb, A. Marton, E. Szabo Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis Crit. Care Med 30 2002 974
18. S.M. Lobo, D. De Backer, Q. Sun Gut mucosal damage during endotoxic shock is due to mechanisms other than gut ischemia J. Appl. Physiol 95 2003 2047
19. P. Pacher, A. Cziraki, J.G. Mabley, L. Liaudet, L. Papp, C. Szabo Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents Biochem. Pharmacol 64 2002 1785
20. P. Pacher, L. Liaudet, J. Mabley, K. Komjati, C. Szabo Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure J. Am. Coll. Cardiol 40 2002 1006
21. P. Pacher, J.G. Mabley, F.G. Soriano, L. Liaudet, C. Szabo Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging Int. J. Mol. Med 9 2002 659
22. G. Szabo, S. Bahrle, N. Stumpf Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation Circ. Res 90 2002 100
23. J. Creteur, D. De Backer, J.L. Vincent Monitoring of gastric mucosal PCO2 by gas tonometry In vitro and in vivo validation studies Anesthesiology 87 1997 504
24. C.J. Chiu, A.H. McArdle, R. Brown, H.J. Scott, F.N. Gurd Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic and metabolic reappraisal Arch. Surg 101 1970 478
25. E.D. Crouser, M.W. Julian, P.M. Dorinsky Ileal VO(2)-DO(2) alterations induced by endotoxin correlate with severity of mitochondrial injury Am. J. Respir. Crit. Care Med 160 1999 1347
26. J.P. Revelly, L. Liaudet, P. Frascarolo, J.M. Joseph, O. Martinet, M. Markert Effects of norepinephrine on the distribution of intestinal blood flow and tissue adenosine triphosphate content in endotoxic shock Crit. Care Med 28 2000 2500
27. F.G. Soriano, L. Liaudet, E. Szabo Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice Shock 17 2002 286
28. S. Cuzzocrea, E. Mazzon, A. De Sarro, A.P. Caputi Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability Mol. Med 6 2000 766
29. A.S. Taner, I. Cinel, L. Ozer, U. Onde, D. Taner, C. Koksoy Poly(ADP-ribose) synthetase inhibition reduces bacterial translocation in rats after endotoxin challenge Shock 16 2001 159
30. D. Avlan, H. Taskinlar, A. Unlu The role of poly (ADP-ribose) synthetase inhibition on the intestinal mucosal barrier after thermal injury Burns 30 2004 785
31. S.M. Lobo, G. Dimopoulos, D. De Backer Effects of a novel poly(ADP-ribose) synthetase inhibitor on serum and luminal gut lactate release in a rabbit model of endotoxic shock Intensive Care Med 27 Suppl 2 2001 S137 (abstract)
32. M. Kennedy, A.G. Denenberg, C. Szabo, A.L. Salzman Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells Gastroenterology 114 1998 510
33. L. Liaudet, F.G. Soriano, E. Szabo Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose) polymerase Proc. Natl. Acad. Sci. USA 97 2000 10203
34. 2 exchange and energy metabolism during hyperdynamic porcine endotoxemia Intensive Care Med 27 2001 586
35. K. Murakami, P. Enkhbaatar, K. Shimoda Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis Shock 21 2004 126
36. L. Liaudet, P. Pacher, J.G. Mabley Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation Am. J. Respir. Crit. Care Med 165 2002 372